Latest "TwoXAR, Inc." News Stories

21:15 EDT 15th October 2018 | BioPortfolio

Here are the most relevant search results for "TwoXAR, Inc." found in our extensive news archives from over 250 global news sources.

More Information about TwoXAR, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about TwoXAR, Inc. for you to read. Along with our medical data and news we also list TwoXAR, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of TwoXAR, Inc. Companies for you to search.

Showing "TwoXAR" News Articles, all 3

Monday 13th August 2018

Twoxar Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14062018] Prices from USD $250

SummaryTwoxar Inc Twoxar is an artificial intelligencedriven drug discovery company that develops novel drug candidates. The company's drug discovery technology platform evaluates public and proprietary datasets to identify high probability drugdisease matches based on orders of magnitude. Its research programs include gene expression, proteininteraction, chemical structure, MOA, and clinical data...

Thursday 29th March 2018

Seed round brings in $3.4mm for twoXAR

One-year-old twoXAR (artificial intelligence-based drug discovery) raised $3.4mm in seed financing led by Andreessen Horowitz...

Series A lands $10mm for twoXAR

TwoXAR Inc. (using artificial intelligence in drug discovery) raised $10mm in a Series A financing led by SoftBank Ventures, ...

Quick Search


News Quicklinks